Apollomics Inc.
APLMdata completeness 100%5 fiscal years on fileData notes: no data for concept 'interestExpense'
Apollomics Inc. earns about -763% on equity, and has bought back 100% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|
| Revenue | $01 | $02 | $03 | $03 | $03 |
| Net income | −$74.8M4 | −$94.8M5 | −$240.8M6 | −$172.6M6 | −$53.9M6 |
| Operating cash flow | −$35.7M7 | −$43.3M8 | −$42.8M9 | −$43.2M9 | −$28.7M9 |
| Capital expenditure | $144,00010 | $50,00011 | $367,00012 | $6,00012 | $24,00012 |
| Free cash flow (derived) | −$35.8M7 | −$43.4M8 | −$43.2M9 | −$43.2M9 | −$28.8M9 |
| Total debt | — | — | — | — | $013 |
| Cash & equivalents | $130.6M14 | $46.7M15 | $32.7M15 | $32.1M15 | $9.77M15 |
| Diluted shares | 361.5M | 28.1M | 285,000 | 744,000 | 1.0M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $47.69 of net worth that earned you −$528.02 and generated −$282.03 of cash last year, against $0 of debt.
It earned an average -763% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 100% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 20-F · period ending 2020-12-31 · accession 0001193125-23-127602 (Revenue)
- 20-F · period ending 2021-12-31 · accession 0000950170-24-038107 (Revenue)
- 20-F · period ending 2022-12-31 · accession 0000950170-25-050531 (Revenue)
- 20-F · period ending 2020-12-31 · accession 0001193125-23-127602 (ProfitLoss)
- 20-F · period ending 2021-12-31 · accession 0000950170-24-038107 (ProfitLoss)
- 20-F · period ending 2022-12-31 · accession 0000950170-25-050531 (ProfitLoss)
- 20-F · period ending 2020-12-31 · accession 0001193125-23-127602 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2021-12-31 · accession 0000950170-24-038107 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2022-12-31 · accession 0000950170-25-050531 (CashFlowsFromUsedInOperatingActivities)
- 20-F · period ending 2020-12-31 · accession 0001193125-23-127602 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2021-12-31 · accession 0000950170-24-038107 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2022-12-31 · accession 0000950170-25-050531 (PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities)
- 20-F · period ending 2024-12-31 · accession 0000950170-25-050531 (Borrowings)
- 20-F · period ending 2020-12-31 · accession 0000950170-24-038107 (CashAndCashEquivalents)
- 20-F · period ending 2021-12-31 · accession 0000950170-25-050531 (CashAndCashEquivalents)